Table of Contents:

Chapter 1. Research Methodology and Scope

• Market Segmentation and Scope
  • Disease Type
  • Drug Class
  • Route of Administration
  • Distribution Channel
  • Region
• Regional Coverage
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
• Objectives
  • To analyze and forecast the global Vasculitis market revenue from 2023 to 2031
  • To outline, categorize, and project the global Vasculitis market on the basis of various segments
  • To forecast each segment's revenue contribution to the market
• Research Methodology
• Primary Research
• Secondary Research
• Assumptions
• IDataAcumen Analysis
• Paid Databases

Chapter 2. Executive Summary

• Market Landscape
  • Brief on Vasculitis, symptoms, pathophysiology, diagnosis, treatments
  • Market size, CAGR, trends, drivers, restraints, opportunities
• Market Size and Forecast
  • Historical and forecasted market size
  • Segment wise and region wise forecasts
• Competitive Landscape
  • Market share analysis of top companies
  • Key strategies adopted by market players
  • Product benchmarks of leading players

Chapter 3. Vasculitis Market: Disease Type Segment Trends, Size, and Future Outlook

• Disease Type Segment Market Size, CAGR, and Forecast (2023-2031)
• Disease Type Segment Technology Landscape
• Disease Type Segment Market Drivers
  • Increasing prevalence of associated autoimmune disorders
  • Advances in diagnosis
  • Rising R&D on biologics targeting disease pathways
• Disease Type Segment Market Restraints
  • High cost of novel therapies
  • Dominance of generic corticosteroids

Chapter 4. Vasculitis Market: Drug Class Segment Trends, Size, and Future Outlook

• Drug Class Segment Market Size, CAGR, and Forecast (2023-2031)
• Drug Class Segment Technology Landscape
• Drug Class Segment Market Drivers
  • Demand for targeted drugs over broad immunosuppressants
  • Strategic partnerships and research collaborations
  • Entry of novel mechanisms like JAK inhibitors
• Drug Class Segment Market Restraints
  • Stringent regulatory environment
  • Longer clinical development timelines

Chapter 5. Vasculitis Market: Route of Administration Segment Trends, Size, and Future Outlook

• Route of Administration Segment Market Size, CAGR, and Forecast (2023-2031)
• Route of Administration Segment Technology Landscape
• Route of Administration Segment Market Drivers
  • Patient preference for self-administration
  • Development of large molecule biologics requiring injection/infusion
• Route of Administration Segment Market Restraints
  • Lack of oral targeted therapies
  • Invasive nature of injectables/infusions

Chapter 6. Vasculitis Market: Distribution Channel Segment Trends, Size, and Future Outlook

• Distribution Channel Segment Market Size, CAGR, and Forecast (2023-2031)
• Distribution Channel Segment Landscape
• Distribution Channel Segment Market Drivers
  • High adoption in hospital pharmacies
  • Rising online pharmacy sales
• Distribution Channel Segment Market Restraints
  • Supply chain disruptions affecting inventory
  • Counterfeiting of drugs

Chapter 7. Vasculitis Market: Regional Market Trends, Size, and Future Outlook

• North America Vasculitis Market Size, CAGR, and Forecast (2023-2031)
  • North America Market Dynamics and Trends
  • North America Market Restraints
  • North America Competitive Landscape
• Europe Vasculitis Market Size, CAGR, and Forecast (2023-2031)
  • Europe Market Dynamics and Trends
  • Europe Market Restraints
  • Europe Competitive Landscape
• Asia Pacific Vasculitis Market Size, CAGR, and Forecast (2023-2031)
  • Asia Pacific Market Dynamics and Trends
  • Asia Pacific Market Restraints
  • Asia Pacific Competitive Landscape
• Latin America Vasculitis Market Size, CAGR, and Forecast (2023-2031)
  • Latin America Market Dynamics and Trends
  • Latin America Market Restraints
  • Latin America Competitive Landscape
• Middle East & Africa Vasculitis Market Size, CAGR, and Forecast (2023-2031)
  • Middle East & Africa Market Dynamics and Trends
  • Middle East & Africa Market Restraints
  • Middle East & Africa Competitive Landscape

Chapter 10. Vasculitis Market: Competitive Landscape

• GlaxoSmithKline
  • Overview
  • Financial Performance
  • Product Portfolio
  • Recent Developments
• Genentech
  • Overview
  • Financial Performance
  • Product Portfolio
  • Recent Developments
• ChemoCentryx
  • Overview
  • Financial Performance
  • Product Portfolio
  • Recent Developments
• Kiniksa Pharmaceuticals
  • Overview
  • Financial Performance
  • Product Portfolio
  • Recent Developments
• Takeda Pharmaceuticals
  • Overview
  • Financial Performance
  • Product Portfolio
  • Recent Developments
• Teijin Pharma
  • Overview
  • Financial Performance
  • Product Portfolio
  • Recent Developments
• Otsuka Pharmaceutical
  • Overview
  • Financial Performance
  • Product Portfolio
  • Recent Developments
• Boehringer Ingelheim
  • Overview
  • Financial Performance
  • Product Portfolio
  • Recent Developments
• Merck & Co.
  • Overview
  • Financial Performance
  • Product Portfolio
  • Recent Developments
• Bristol-Myers Squibb
  • Overview
  • Financial Performance
  • Product Portfolio
  • Recent Developments
• F. Hoffmann-La Roche
  • Overview
  • Financial Performance
  • Product Portfolio
  • Recent Developments
• Eli Lilly
  • Overview
  • Financial Performance
  • Product Portfolio
  • Recent Developments
• AbbVie
  • Overview
  • Financial Performance
  • Product Portfolio
  • Recent Developments
• Amgen
  • Overview
  • Financial Performance
  • Product Portfolio
  • Recent Developments
• Pfizer
  • Overview
  • Financial Performance
  • Product Portfolio
  • Recent Developments
• Johnson & Johnson
  • Overview
  • Financial Performance
  • Product Portfolio
  • Recent Developments
• Momenta Pharmaceuticals
  • Overview
  • Financial Performance
  • Product Portfolio
  • Recent Developments
• Emergent BioSolutions
  • Overview
  • Financial Performance
  • Product Portfolio
  • Recent Developments
• EMD Serono
  • Overview
  • Financial Performance
  • Product Portfolio
  • Recent Developments
• Biogen
  • Overview
  • Financial Performance
  • Product Portfolio
  • Recent Developments
• Other Companies

Chapter 11. Research Methodology

• Primary Research
• Secondary Research
• Assumptions
• IDataAcumen Analysis
• Paid Databases

Appendix

• About Us